4 things to look for when choosing a long-term care facility for a loved one
(feeds.feedburner.com)
31.
32.
33.
Show HN: difi – A Git diff TUI with Neovim integration (written in Go)
(news.ycombinator.com)
34.
Ontogeny and transcriptional regulation of Thetis cells
(feeds.nature.com)
35.
Why the Trump administration is watering down the definition of ‘doxxing’
(feeds.feedburner.com)
36.
Why Smart Marketers Treat This Investment the Way CEOs Treat Buildings
(feeds.feedburner.com)
37.
38.
Why you should treat your brand as an operating system
(feeds.feedburner.com)
39.
L∃AN together – live stream schedule
(news.ycombinator.com)
40.
CEOs Say AI Is Making Work More Efficient. Employees Tell a Different Story.
(feeds.content.dowjones.io)
41.
Are you ‘grounded’ or in a rut in your career? ‘Stable’ or stuck?
(feeds.feedburner.com)
42.
Why Is ‘Avengers: Doomsday’ Being Marketed Like This?
(gizmodo.com)
43.
Saying ‘I don’t know’ might be the best leadership decision I’ve made. Here’s why
(feeds.feedburner.com)
44.
Why Most Managers Avoid Hard Conversations — and How to Stop Letting It Cost You Millions
(feeds.feedburner.com)
45.
Side-by-side comparison of how AI models answer moral dilemmas
(news.ycombinator.com)
46.
Android’s time zone change notification might not leave you guessing anymore
(androidauthority.com)
47.
Why you need a devil’s advocate
(feeds.feedburner.com)
48.
49.
Your mind needs a training plan, here’s how to build one
(feeds.feedburner.com)
50.
51.
Tiger Moms Battle for the Hottest Ticket in China: a Tour of a Factory Floor
(feeds.content.dowjones.io)
52.
The Hardest Reservation in China Is a Factory Tour
(feeds.content.dowjones.io)
53.
The Riven Diffs – Seeing Riven (1997) Differently
(news.ycombinator.com)
54.
The Riven (1997) Diffs
(news.ycombinator.com)
55.
UK company sends factory with 1,000C furnace into space
(news.ycombinator.com)
56.
57.
Ask HN: Any example of successful vibe-coded product?
(news.ycombinator.com)
58.
When a driver challenges the kernel's assumptions
(news.ycombinator.com)
59.
60.
Non-equilibrium snapshots of ligand efficacy at the μ-opioid receptor
(feeds.nature.com)